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TABLE 1. Parameters of the receiver operating characteristic curve after generalized linear modeling
Surgical procedure Value 95% Confidence interval P value
Intercept 1.22  0.10 1.04–1.45 <.05
Slope 0.91  0.08 0.78–1.1 <.05
Effect of mitral surgery on intercept 0.38  0.16 0.68 to 0.06 <.05
Effect of mitral surgery on slope 0.36  0.10 0.57 to 0.15 <.05
Receiver operating characteristic curve is defined by 2 parameters, intercept and slope. The only covariate significantly affecting the receiver operating characteristic curve
parameters was mitral valve surgery, which negatively affected discriminative performance.
Brief Research Reportsintervention, and different surgical procedures are therefore
expected to exert different effects on the prediction of
in-hospital mortality. The Society of Thoracic Surgeons
score was developed from data from distinct surgical
populations, and the weight of procedures in risk prediction
was underscored and included in the model.4 In contrast, the
recently released euroSCORE II categorizes surgeries in
general classes, privileging the role of the number of
procedures without differentiating among non-CABG
procedures.1 In this analysis, we have demonstrated that
the discriminative performance of euroSCORE II is higher
for surgical categories included in the algorithm, such as
CABG or surgery for aortic disease, whereas it decreases
in other classes. Nonetheless, the only covariate that
significantly affects the ROC curve is surgery for mitral
disease, which decreases the performance of the score.
The discriminative power of euroSCORE II significantly
worsens when applied to mitral surgery, although it still
remains satisfactory (AUC 0.79, 95% CI 0.74-0.84).
Previous validation studies have demonstrated good
discrimination in the case of both isolated CABG and aortic
valve replacement, although no composite evaluation of all
surgical subgroups has been performed.5,6
The identification of independent predictors of discrimi-
natory accuracy should lead to covariate adjustment or to
the incorporation of such factors in the score algorithm.
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The Journal of Thoracic and Cato focus in addition on the roles of diverse surgical
techniques for the same disease, because the classification
of surgeries that we tested is generic. The general category
‘‘surgery for mitral disease,’’ and also other surgical
categories, includes different treatment options that can
have an effect on outcomes.
The more complex categorization introduced in the
updated euroSCORE II to update the older versions still
seems inadequate. Further testing and refinement of the
algorithm should include further surgical categories, and
even subcategories.References
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Gilbert Massard, MD, PhD, FETS, Strasbourg, FrancePatients listed for lung transplants still suffer from lack of
available donor organs. In France between 2004 and
2009, an average of 31 patients yearly died while on the
waiting list.1 Single-lung transplants (SLTs) have the theo-
retic advantage of increasing access to transplantation by
sharing a single donor between 2 recipients who become
‘‘twinned.’’ Twinned SLTs (TSLTs) are feasible even in a
single center, without impairment of outcome in the second
recipient despite longer ischemia.2 The real benefit of TSLTrdiovascular Surgery c Volume 146, Number 4 987
TABLE 1. Criteria for lung quality
Ideal donor Acceptable donor Improper donor
PaO2 (mm Hg) >300 >300 >300
Defaults None 1 2
Age (y) <55 >55 >55
And Or And/or
Mechanical ventilation (h) <48 >48 >48
And Or And/or
Tracheal secretions Clean Stained Stained
And Or And/or
Chest radiograph Clear Abnormal (mild pleural effusion, atelectasis,
lung infiltrates, aspiration)
Abnormal (mild pleural effusion, atelectasis,
lung infiltrates, aspiration)
Brief Research Reportshas not been studied on a national level as yet. To do so, we
studied how often and why the second donor lung had not
been transplanted.
MATERIALS AND METHODS
We collected clinical data from all SLTs recorded in the French national
registry on solid organ transplantation run by the Agence de Biomedecine
between January 1, 1998, and December 31, 2008. We differentiated all
TSLTs from SLTs in which the second donor lung was not used.
When the second lung was not listed as implanted, we first recorded the
reason indicated in the registry: not offered, considered as poor quality, no
appropriate recipient, and team logistics.We next retrospectively estimated
quality of donor lungs, thus distinguishing among ideal donors, acceptable
donors, and improper donors (Table 1). We also screened for asymmetric
quality of the donor lungs.
RESULTS
Lung harvesting from 297 donors led to 387 SLTs. Both
lungs were used for 2 different recipients in 90 donors only
(180 TSLTs). In the case of the remaining 207 donors, only
a single lung was transplanted. In 115 donors (39% of
donors, 55% of rejected lungs), the opposite lung was
turned down for asymmetric quality. The main causes for
asymmetric quality were aspiration and trauma. In 92 do-
nors (31% of donors, 44% of rejected lungs), the second
lung could have been used for TSLT or bilateral lung
transplant (BLT; Table 2): there were 31 ideal grafts
(10%) and 61 acceptable grafts (21%) with only a singleTABLE 2. Schematic overview of single-lung graft proposals between 199
297 single-lung graft donors
TSLT: 90 donors, 180 twinned SLT recipients SLT: 207 donors, 207 SLT re
115 donors, asymmetric qua
unsuitable for transplant
TSLT, Twinned single-lung transplant; SLT, single-lung transplant; BLT, bilateral lung tran
988 The Journal of Thoracic and Cardiovascular Surgflawed parameter (except for PaO2, which was always
>300 mm Hg).
Nonuse of those 92 grafts for TSLTwas based on a deci-
sion by the coordinator not to offer the graft in 23%, size
inadequacy with respect to the recipient in 20%, lack of
blood group–matched recipient in 19%, team logistics in
10%, and miscellaneous reasons in 28% (Table 2).
Nonuse of those 92 grafts for BLT was based on a deci-
sion by the coordinator not to offer the graft in 33%, size
inadequacy with respect to the potential double-lung recip-
ient in 22%, lack of blood group–matched double-lung
recipient in 21%, team logistics in 17%, and miscellaneous
reasons in 7% (Table 2).
DISCUSSION
During a 10-year period, 92 single-lung grafts (31%)
were not used for either TSLT or BLT. Concurrently, a
mean of 9 grafts per year were lost, while an average of
31 patients died yearly while on the waiting list. In our eval-
uation, we applied strict quality criteria as used in the early
2000s. We know that during the course of this experience,
selection criteria have become less restrictive and the donor
pool has increased. The number of acceptable lungs is thus
probably underestimated in this evaluation.
The lack of blood group- or size-matched recipients was
the main cause of refusal of otherwise acceptable second8 and 2008
cipients; single graft transplanted, loss of opposite lung graft
lity of opposite lung, 92 donors, ideal or acceptable opposite lung but
discarded for transplant
Not used for BLT: not offered by organ sharing
coordinator (33%); size inadequacy graft/
recipient (22%); lack of recipient (21%); lack
of logistic support (17%)
Not used for SLT: not offered by organ-sharing
coordinator (23%); size inadequacy graft/
recipient (20%); lack of recipient (19%); lack
of logistic support (10%)
splant.
ery c October 2013
Brief Research Reportslungs. In our study, 29 of the 62 acceptable or ideal donors
(47%) were taller than 180 cm; only 10 (16%) were shorter
than 155 cm. Size inadequacy is a difficult issue; a larger
graft can be reduced, but a smaller graft cannot be
increased.3
The second cause for nonuse was the organ sharing co-
ordinator’s decision to offer the opposite lung neither for
TSLT nor for BLT. Well-established rules allow the coor-
dinator not to offer the second single lung when no
matched recipient is identified on the waiting list or
when organization of the second lung harvest will require
additional time until acceptance and effective organ
retrieval. Nevertheless, because BLT offers best survival
to lung transplant recipients,4 bilateral lung graft offer
should be prioritized. When BLT is not feasible, TSLT
should be performed whenever possible to avoid spoiling
single-lung grafts. In our study, TSLT efficiently used aThe Journal of Thoracic and Cathird of available donor resources, in contrast with some
other countries, in which TSLT accounts for fewer than
5% of all lung transplants.5
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